InternationalUSRemember you can easily switch between MIP US and MIP International at any time

China leads the world in PCT growth

Managing Intellectual Property


Joe Biden said the Chinese can’t innovate. But new figures show that PCT applications from China grew by a third last year – and for the first time a Chinese company is ranked number one for published patents

WIPO’s annual PCT statistics, published today, show that applications from the so-called BRIC markets are soaring.

Filings from China grew by 33.4% last year, making the country the fourth biggest source of PCT applications, behind the United States, Japan and Germany.

Applications from Russia were up 20.8%, those from Brazil up 17.2% and those from...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Future of Urban Innovation: Startups - event hosted by @uspto & @Columbia on 9 June in NYC. Details & registration http://t.co/mdtecCnmwk

May 28 2015 03:18 ·  reply ·  retweet ·  favourite
ManagingIP profile

Trademark registration & renewal fees to soar by 100% in UAE tomorrow - details ($/trial) http://t.co/6Nrt6FUvst http://t.co/HguB2fHD69

May 28 2015 03:11 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @mdloney: Are more changes needed to IPR proceedings? My latest @ManagingIP blog post http://t.co/9I2lbHYkI7 http://t.co/KzYwD7rX3j

May 28 2015 03:07 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


INTA Daily News 2015

Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego


June 2015

The fine line between abuse and fair use at the PTAB

Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system



Most read articles

Supplements